Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Infiltrates”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05902520
What this trial is testing

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors

Who this might be right for
HNSCCMelanomaGynecologic Cancer+3 more
AgonOx, Inc. 18
Not applicableStudy completedNCT01865513
What this trial is testing

POPULAR: POst-operative PULmonary Complications After Use of Muscle Relaxants in Europe

Who this might be right for
Surgical Procedures, OperativeAnaesthesia
European Society of Anaesthesiology 22,000
Not applicableLooking for participantsNCT06837909
What this trial is testing

Transversus Abdominis Plane Block Versus Wound Infiltration for Pulmonary Function Preservation Following Laparoscopic Living Donor Nephrectomy

Who this might be right for
Postoperative Pain
Rabin Medical Center 80
Testing effectiveness (Phase 2)Looking for participantsNCT07444437
What this trial is testing

A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Suzhou BlueHorse Therapeutics Co., Ltd. 45
Not applicableEnded earlyNCT06519669
What this trial is testing

Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer

Who this might be right for
AdultLung Cancer
Grit Biotechnology 2
Not applicableStudy completedNCT02848872
What this trial is testing

Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Carcinoma
Duke University 25
Not applicableStudy completedNCT00914550
What this trial is testing

Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia

Who this might be right for
PneumoniaRadiographic Lung Infiltrates
Winthrop University Hospital 47
Testing effectiveness (Phase 2)Looking for participantsNCT07330037
What this trial is testing

TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 41
Not applicableActive Not RecruitingNCT06876402
What this trial is testing

Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Hellenic Cooperative Oncology Group 367
Not applicableStudy completedNCT01328873
What this trial is testing

FOB in HSCT and Leukemia Patients With Acute Respiratory Symptoms and Pulmonary Infiltrates

Who this might be right for
Pulmonary Infiltrate New
Northside Hospital, Inc. 49
Early research (Phase 1)Looking for participantsNCT06375187
What this trial is testing

GC203 TIL in Advanced Malignant Solid Tumors

Who this might be right for
Solid TumorGynecologic CancerBreast Cancer+2 more
Shanghai Juncell Therapeutics 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06237881
What this trial is testing

KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaLung Neoplasms+1 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT02414945
What this trial is testing

TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients

Who this might be right for
Pleural Mesothelioma
University Health Network, Toronto 9
Testing effectiveness (Phase 2)Looking for participantsNCT04614103
What this trial is testing

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 170
Not applicableStudy completedNCT00846352
What this trial is testing

Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients

Who this might be right for
Bone Marrow Transplantation
Wake Forest University Health Sciences 22
Not applicableLooking for participantsNCT02139163
What this trial is testing

Epidemiological Study on Community Acquired Pneumonia

Who this might be right for
Community Acquired Pneumonia
Capnetz Stiftung 20,000
Not applicableLooking for participantsNCT06656299
What this trial is testing

EOIB for Laparoscopic Cholecystectomy

Who this might be right for
CholecystitisCholecystitis, AcuteCholecystitis, Chronic+1 more
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital 60
Not applicableUnknownNCT06356038
What this trial is testing

Phrenic Nerve Infiltration: Pulmonary Expansion and Pain Control

Who this might be right for
Prolonged Air LeakPost-operative Pain
Azienda Ospedaliera "Sant'Andrea" 66
Not applicableUnknownNCT04241497
What this trial is testing

Home-based Exercise Training in Patients With Pulmonary Arterial Hypertension: Effect on Skeletal Muscular Function and Metabolism

Who this might be right for
Pulmonary Arterial HypertensionExercise TrainingHome-based Rehabilitation+5 more
Laval University 10
Testing effectiveness (Phase 2)Ended earlyNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 225
Next Page